Dihydroproscar

98%

Reagent Code: #92893
label
Alias N-tert-butyl-3-oxo-4-aza-5Α-androst-17Β-carboxamide; F9 / FINASTERIDE INTERMEDIATE; F9(3-keto-4-aza-5Α-androst-17Β-tert Butanamide) (127,000 ); N-tert-butyl-3-oxo-4-aza-5alpha-androst-17beta-carboxamide; Dihydroposcar (finasteride intermediate); 3-Oxo- 4-aza-5α-androstane-17β-(N-t-butylcarboxamide);
fingerprint
CAS Number 98319-24-5

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 374.56 g/mol
Formula C₂₃H₃₈N₂O₂
badge Registry Numbers
MDL Number MFCD00214352
thermostat Physical Properties
Boiling Point 569.397ºC
inventory_2 Storage & Handling
Density 1.051g/cm3
Storage -20°C

description Product Description

Used primarily in the treatment of benign prostatic hyperplasia (BPH), it helps reduce the size of an enlarged prostate, alleviating symptoms such as difficulty in urination. It works by inhibiting the enzyme responsible for converting testosterone to dihydrotestosterone (DHT), a hormone that contributes to prostate growth. Additionally, it is sometimes prescribed to lower the risk of urinary retention and the need for prostate surgery. It may also be used in combination with other medications for managing hair loss in men, as DHT is linked to male pattern baldness. Regular monitoring is advised to assess its effectiveness and manage potential side effects.

format_list_bulleted Product Specification

Test Parameter Specification
Appearance White Solid
Purity 98-100
Infrared Spectrum Conforms to Structure

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 1g
10-20 days ฿2,780.00
inventory 5g
10-20 days ฿8,980.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB